Free Trial

AIM ImmunoTech (AIM) News Today

AIM ImmunoTech logo
$0.09 -0.03 (-22.34%)
As of 04/4/2025
This is a fair market value price provided by Polygon.io. Learn more.
AIM ImmunoTech Inc AIMI
AIM ImmunoTech Inc trading halted, news pending
Q4 2024 AIM ImmunoTech Inc Earnings Call
AIM ImmunoTech made ‘significant strides’ over course of 2024
Earnings Preview For AIM ImmunoTech
AIM ImmunoTech Appoints David Chemerow to Board
AIM ImmunoTech doses first subject in Phase 2 study of Ampligen, Imfinzi
AIM ImmunoTech highlights new article on links between COVID-19, ME/CFS
AIM ImmunoTech highlights 2024 milestones achieved
AIM ImmunoTech receives noncompliance notification from NYSE
Get AIM ImmunoTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter.

AIM Media Mentions By Week

AIM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AIM
News Sentiment

0.00

0.57

Average
Medical
News Sentiment

AIM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AIM Articles
This Week

1

2

AIM Articles
Average Week

Get AIM ImmunoTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:AIM) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners